Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: Results from HOST-REDUCE-POLYTECH-ACS trial
- Eur. Heart J. Cardiovasc. Pharmacother., 2023 Jan 28;pvad008 | https://doi.org/10.1093/ehjcvp/pvad008